Medication Prescribing Observations in Care Transitions for Incarcerated Patients.

IF 0.9 Q4 PHARMACOLOGY & PHARMACY
Bethany R Shoulders, Kelly L Maguigan, Stephen J Lemon
{"title":"Medication Prescribing Observations in Care Transitions for Incarcerated Patients.","authors":"Bethany R Shoulders, Kelly L Maguigan, Stephen J Lemon","doi":"10.1177/00185787251407057","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Typical strategies for obtaining medication lists may be suboptimal for incarcerated individuals due to unavailability of electronic transmission and verification methods, leading to potential delays and inaccuracies during care transitions. This study reviews disease states and medication lists at admission and discharge for incarcerated patients at a large academic medical center, hypothesizing that discrepancies in chronic disease diagnoses and medication lists exist during these care transitions.</p><p><strong>Methods: </strong>A retrospective, single-cohort analysis from January 1, 2017 to December 31, 2020, evaluated medication lists in incarcerated adults. Medication lists and chronic disease states, as defined by the Charlson comorbidity index, were assessed at 2 critical care transitions: on admission and at discharge. Pre-specified co-morbidities were selected to identify discrepancies involving missing or duplicate medications.</p><p><strong>Results: </strong>Of 557 eligible patients, 417 (75%) had active prescriptions on admission, averaging 8 medications per patient. Diagnostic discrepancies were infrequent upon admission and at discharge (3.9%), with conditions more often noted for the first time at discharge. In reviewing 309 patients with pre-specified co-morbidities, 55% exhibited at least 1 medication discrepancy, with an average of 1.65 co-morbidities reviewed per patient.</p><p><strong>Conclusion: </strong>The healthcare teams caring for incarcerated patients face unique challenges in medication management during hospital transitions. These medication lists are characterized by a high incidence of medication discrepancies despite a low incidence of diagnostic differences. To enhance care continuity and minimize risks, healthcare systems need to implement streamlined, standardized medication reconciliation processes and improve institutional policies to better support this vulnerable population.</p>","PeriodicalId":13002,"journal":{"name":"Hospital Pharmacy","volume":" ","pages":"00185787251407057"},"PeriodicalIF":0.9000,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12815619/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hospital Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/00185787251407057","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Typical strategies for obtaining medication lists may be suboptimal for incarcerated individuals due to unavailability of electronic transmission and verification methods, leading to potential delays and inaccuracies during care transitions. This study reviews disease states and medication lists at admission and discharge for incarcerated patients at a large academic medical center, hypothesizing that discrepancies in chronic disease diagnoses and medication lists exist during these care transitions.

Methods: A retrospective, single-cohort analysis from January 1, 2017 to December 31, 2020, evaluated medication lists in incarcerated adults. Medication lists and chronic disease states, as defined by the Charlson comorbidity index, were assessed at 2 critical care transitions: on admission and at discharge. Pre-specified co-morbidities were selected to identify discrepancies involving missing or duplicate medications.

Results: Of 557 eligible patients, 417 (75%) had active prescriptions on admission, averaging 8 medications per patient. Diagnostic discrepancies were infrequent upon admission and at discharge (3.9%), with conditions more often noted for the first time at discharge. In reviewing 309 patients with pre-specified co-morbidities, 55% exhibited at least 1 medication discrepancy, with an average of 1.65 co-morbidities reviewed per patient.

Conclusion: The healthcare teams caring for incarcerated patients face unique challenges in medication management during hospital transitions. These medication lists are characterized by a high incidence of medication discrepancies despite a low incidence of diagnostic differences. To enhance care continuity and minimize risks, healthcare systems need to implement streamlined, standardized medication reconciliation processes and improve institutional policies to better support this vulnerable population.

监禁患者护理转变中的药物处方观察。
背景:由于缺乏电子传输和验证方法,获取药物清单的典型策略可能对被监禁者不太理想,导致护理过渡期间潜在的延迟和不准确。本研究回顾了一家大型学术医疗中心监禁患者入院和出院时的疾病状态和药物清单,假设在这些护理过渡期间存在慢性疾病诊断和药物清单的差异。方法:从2017年1月1日至2020年12月31日进行回顾性单队列分析,评估被监禁成年人的药物清单。根据Charlson合并症指数定义的药物清单和慢性疾病状态在入院和出院时的2个重症监护过渡期间进行评估。选择预先指定的合并症来确定涉及缺失或重复药物的差异。结果:在557例符合条件的患者中,417例(75%)在入院时有有效处方,平均每位患者8种药物。入院时和出院时诊断差异不常见(3.9%),出院时首次发现的情况更多。在回顾了309例有预先指定的合并症的患者后,55%的患者表现出至少1种药物差异,平均每位患者回顾了1.65种合并症。结论:在医院转院期间,护理在押患者的医疗团队在药物管理方面面临着独特的挑战。这些药物清单的特点是,尽管诊断差异的发生率很低,但药物差异的发生率很高。为了提高护理的连续性并将风险降至最低,卫生保健系统需要实施简化、标准化的药物和解流程,并改进机构政策,以更好地支持这一弱势群体。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Hospital Pharmacy
Hospital Pharmacy PHARMACOLOGY & PHARMACY-
CiteScore
1.70
自引率
0.00%
发文量
63
期刊介绍: Hospital Pharmacy is a monthly peer-reviewed journal that is read by pharmacists and other providers practicing in the inpatient and outpatient setting within hospitals, long-term care facilities, home care, and other health-system settings The Hospital Pharmacy Assistant Editor, Michael R. Cohen, RPh, MS, DSc, FASHP, is author of a Medication Error Report Analysis and founder of The Institute for Safe Medication Practices (ISMP), a nonprofit organization that provides education about adverse drug events and their prevention.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书